Mathematical models of lipoprotein metabolism and kinetics: Current status and future perspective

Clinical Lipidology

Volumn 8, Issue 5, 2013, Pages 595-604

  Lu, James ^a   Mazer, Norman A ^a   Hübner, Katrin ^b  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

HDL; lipoprotein metabolism; lipoprotein structure models; mathematical modeling; mechanistic model; molecular dynamics; reverse cholesterol transport; statistical model; tracer kinetics; whole body model

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; CHOLESTEROL ESTER; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CARDIOVASCULAR RISK; COMPUTER MODEL; HIGH RISK PATIENT; LIPID ANALYSIS; LIPID TRANSPORT; LIPIDOMICS; LIPOPROTEIN METABOLISM; MATHEMATICAL MODEL; MOLECULAR DYNAMICS; MOLECULAR MODEL; PARTICLE SIZE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROTEIN DETERMINATION; REVIEW; STATISTICAL MODEL; STRUCTURE ANALYSIS;

EID: 84884581907     PISSN: 17584299     EISSN: 17584302     Source Type: Journal    
DOI: 10.2217/clp.13.52     Document Type: Review

References (40)

1. Hübner K, Sahle S, Kummer U. Applications and trends in systems biology in biochemistry. FEBS J. 278(16), 2767-2857 (2012
2. de Graaf AA, van Schalkwijk DB. Computational models for analyzing lipoprotein profiles. Clin. Lipidol. 6(1), 25-33 (2011
3. Parhofer KG, Barrett PH. Thematic review series: Patient-oriented research. What we have learned about VLDL and LDL metabolism from human kinetics studies. J. Lipid Res. 47(8), 1620-1630 (2006
4. Barrett PH, Chan DC, Watts GF. Thematic review series: Patient-oriented research. Design and analysis of lipoprotein tracer kinetics studies in humans. J. Lipid Res. 47(8), 1607-1619 (2006
5. Rashid S, Patterson BW, Lewis GF. Thematic review series: Patient-oriented research. What have we learned about HDL metabolism from kinetics studies in humans?. J. Lipid Res. 47(8), 1631-1642 (2006
6. Larach DB, deGoma EM, Rader DJ. Targeting high density lipoproteins in the prevention of cardiovascular disease?. Curr. Cardiol. Rep. 14, 684-691 (2012
7. Schwartz GG, Olsson AG, Ballantyne CM et al. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N. Engl. J. Med. 367(22), 2089-2099 (2012
8. Shen BW, Scanu AM, Kézdy FJ. Structure of human serum lipoproteins inferred from compositional analysis. Proc. Natl Acad. Sci. USA 74(3), 837-841 (1977
9. Durrant JD, McCammon JA. Molecular dynamics simulations and drug discovery. BMC Biol. 9, 71 (2011
10. Vuorela T, Catte A, Niemelä PS et al. Role of lipids in spheroidal high density lipoproteins. PLoS Comput. Biol. 6(10), e1000964 (2010
11. Wu Z, Gogonea V, Lee X et al. The low resolution structure of apoA1 in spherical high density lipoprotein revealed by small angle neutron scattering. J. Biol. Chem. 286(14), 12495-12508 (2011
12. Silva RA, Huang R, Morris J et al. Structure of apolipoprotein A-I in spherical high density lipoproteins of different sizes. Proc. Natl Acad. Sci. USA 105(34), 12176-12181 (2008
13. Huang R, Silva RA, Jerome WG et al. Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma. Nat. Struct. Mol. Biol. 18(4), 416-422 (2011
14. Yetukuri L, Huopaniemi I, Koivuniemi A et al. High density lipoprotein structural changes and drug response in lipidomic profiles following the long-term fenofibrate therapy in the FIELD substudy. PLoS ONE 6(8), e23589 (2011
15. Mazer NA, Giulianini F, Paynter NP, Jordan P, Mora S. A comparison of the theoretical relationship between HDL size and the ratio of HDL cholesterol to apolipoprotein A-I with experimental results from the women's health study. Clin. Chem. 59(6), 949-958 (2013
16. Kontush A, Chapman MJ. Lipidomics as a tool for the study of lipoprotein metabolism. Curr. Atheroscler. Rep. 12(3), 194-201 (2010
17. Meikle PJ, Christopher MJ. Lipidomics is providing new insight into the metabolic syndrome and its sequelae. Curr. Opin. Lipidol. 22(3), 210-215 (2011
18. Kiebish MA, Bell R, Yang K et al. Dynamic simulation of cardiolipin remodeling: Greasing the wheels for an interpretative approach to lipidomics. J. Lipid Res. 51(8), 2153-2170 (2010
19. Sysi-Aho M, Vehtari A, Velagapudi VR et al. Exploring the lipoprotein composition using Bayesian regression on serum lipidomic profiles. Bioinformatics 23(13), 519-528 (2007
20. Puri R, Duong M, Uno K, Kataoka Y, Nicholls SJ. The emerging role of plasma lipidomics in cardiovascular drug discovery. Expert Opin. Drug Discov. 7(1), 63-72 (2012
21. Bergheanu SC, Reijmers T, Zwinderman AH et al. Lipidomic approach to evaluate rosuvastatin and atorvastatin at various dosages: Investigating differential effects among statins. Curr. Med. Res. Opin. 24(9), 2477-2487 (2008
22. van Bochove K, van Schalkwijk DB, Parnell LD et al. Clustering by plasma lipoprotein profile reveals two distinct subgroups with positive lipid response to fenofibrate therapy. PLoS ONE 7(6), e38072 (2012
23. Chétiveaux M, Ouguerram K, Zair Y et al. New model for kinetic studies of HDL metabolism in humans. Eur. J. Clin. Invest. 34(4), 262-267 (2004
24. Shah A, Rader DJ, Millar JS. The effect of PPAR-a agonism on apolipoprotein metabolism in humans. Atherosclerosis 1, 35-40 (2010
25. Schwartz CC, Berman M, Vlahcevic ZR, Swell L. Multicompartmental analysis of cholesterol metabolism in man. Quantitative kinetic evaluation of precursor sources and turnover of high density lipoprotein cholesterol esters. J. Clin. Invest. 70(4), 863-876 (1982
26. Schwartz CC, VandenBroek JM, Cooper PS. Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans. J. Lipid Res. 45(9), 1594-1607 (2004
27. Ouguerram K, Krempf M, Maugeais C, Maugère P, Darmaun D, Magot T. A new labeling approach using stable isotopes to study in vivo plasma cholesterol metabolism in humans. Metabolism 51(1), 5-11 (2002
28. Turner S, Voogt J, Davidson M et al. Measurement of reverse cholesterol transport pathways in humans: In vivo rates of free cholesterol efflux, esterification, and excretion. J. Am. Heart Assoc. 4, e001826 (2012
29. Funahashi A, Tanimura N, Morohashi M, Kitano H. CellDesigner: A process diagram editor for gene-regulatory and biochemical networks. BIOSILICO 1, 159-162 (2003
30. Mendes P, Hoops S, Sahle S, Gauges R, Dada J, Kummer U. Computational modeling of biochemical networks using COPASI. Methods Mol. Biol. 500, 17-59 (2009
31. Barrett PH, Bell BM, Cobelli C et al. SAAM II: Simulation, analysis, and modeling software for tracer and pharmacokinetic studies. Metabolism 47, 484-492 (1998
32. Potter LK, Sprecher DL, Walker MC, Tobin FL. Mechanism of inhibition defines CETP activity: A mathematical model for CETP in vitro. J. Lipid Res. 50(11), 2222-2234 (2009
33. Knoblauch H, Schuster H, Luft FC, Reich JG. A pathway model of lipid metabolism to predict the effect of genetic variability on lipid levels. J. Mol. Med. 78, 507-515 (2000
34. Hübner K, Schwager T, Winkler K, Reich JG, Holzhütter HG. Computational lipidology: Predicting lipoprotein density profiles in human blood plasma. PLoS Comput. Biol. 4, e1000079 (2008
35. van Schalkwijk DB, van Ommen B, Freidig AP, van der Greef J, de Graaf AA. Diagnostic markers based on a computational model of lipoprotein metabolism. J. Clin. Bioinforma. 1(1), 29 (2011
36. McAuley MT, Wilkinson DJ, Jones JJ, Kirkwood TB. A whole-body mathematical model of cholesterol metabolism and its age-associated dysregulation. BMC Syst. Biol. 6, 130 (2012
37. van de Pas NC, Woutersen RA, van Ommen B, Rietjens IM, de Graaf AA. A physiologically based in silico kinetic model predicting plasma cholesterol concentrations in humans. J. Lipid Res. 53(12), 2734-2746 (2012
38. Lu J, Nanjee MN, Brinton EA, Hübner K, Mazer NA. ABCA1 up-regulation but not CETP inhibition is predicted to increase the reverse cholesterol transport (RCT) input rate: A simulation study of HDL-C raising targets using a novel in-silico model of lipoprotein metabolism and kinetics. Arterioscler. Thromb. Vasc. Biol. Abstract 443 (2013
39. Lu J, Hübner K, Brinton EA, Nanjee MN, Mazer NA. Association between reverse cholesterol transport rate and lipoprotein biomarkers using a novel in silico model of lipoprotein metabolism and kinetics. Eur. Atheroscler. Soc. Congr. Abstract A-547-0010-01108 (2013
40. McIntosh JEA, McIntosh RP. Mathematical Modeling and Computers in Endocrinology. Springer Verlag, Berlin, Germany (1980